7th
Urologic Oncology:Advances in Clinical Practice
November 2–3, 2012MD Anderson, Dan L. Duncan BuildingFloor 8 Conference Center, 1155 Pressler, Houston, Texas
Nursing Session – November 2, 2012Urologic Oncology:Nursing Advances in Clinical PracticeMD Anderson, Mays Clinic, ACB1.23451220 Holcombe Boulevard, Houston, Texas
FocusThe 7th Urologic Oncology Conference will focus on the diagnosis, treatment, clinical advances, and controversies in localized and advanced cancers of the bladder, prostate and kidney.
Educational ObjectivesAfter attending the conference, participants should be able to• illustrateandimplementclinicaladvancesinthediagnosisandevaluationofbladder,prostate,andkidneycancers(knowledge, competence, performance, patient outcomes);
• illustrateandimplementclinicaladvancesinthetreatmentapproachtolocalizedandlocallyadvancedbladder,prostateandkidneycancers,includingtheroleofminimallyinvasiveroboticsurgery(knowledge, competence, performance, patient outcomes);
• illustrateandimplementclinicaladvancesinthetreatmentapproachtometastaticbladder,prostateandkidneycancers(knowledge, competence, performance, patient outcomes);
• identifycontemporarycontroversiesinthemanagementofbladder,prostateandkidneycancers(knowledge).
Educational MethodsLectures – Case Presentations – Panel Discussions – Audience Response System – Question and Discussion Sessions
7th Urologic Oncology: Advances in Clinical PracticeNovember 2-3, 2012
Nursing Session – November 2, 2012Urologic Oncology: Nursing Advances in Clinical Practice
EvaluationAcourseevaluationformwillprovideparticipantswiththeopportunitytocommentonthevalueoftheprogramcontenttotheirpracticedecisions,performanceimprovementactivities,orpossibleimpactonpatienthealthstatus.Participantswillalsohavetheopportunitytocommentonanyperceivedcommercialbiasinthepresentationsaswellastoidentifyfutureeducationaltopics.
Accreditation/Credit DesignationPhysiciansTheUniversityofTexasMDAndersonCancerCenterisaccreditedbytheAccreditationCouncilforContinuingMedicalEducationtoprovidecontinuingmedicaleducationforphysicians.
TheUniversityofTexasMDAndersonCancerCenterdesignatesthisliveactivityforamaximumof13.25 AMA PRA Category 1 CreditsTM.Physiciansshouldclaimonlythecreditcommensuratewiththeextentoftheirparticipationintheactivity.
Target AudienceThis conference should be of value to urologists, medical oncologists, nurses, nurse practitioners, and physician assistants.
CME Certificates and Attendance Verification CertificatesCertificatesawardingAMA PRA Category 1 CreditTMorcertificatesdocumentingattendancewillbedistributedtoparticipantsastheydepartthesymposium.ToobtainaCMEcertificate,physiciansmustsubmitacompletedevaluationquestionnaireandaCME Verification Form.
Uponrequest,arecordofattendance(certificate)willbeprovidedon-sitetootherhealthcareprofessionalsforrequestingcreditsinaccordancewithstatenursingboards,specialtysocieties,orotherprofessionalassociations.
Christopher G. Wood, MDProgram Co-ChairmanProfessor and Vice ChairmanUrology
Nizar M. Tannir, MDProgram Co-ChairmanAssociate Professor and Vice ChairmanGenitourinary Medical Oncology
Seungtaek Choi, MDAssistant ProfessorRadiation Oncology
Gloria CurtisSenior Administrative AssistantGenitourinary Medical Oncology
John W. Davis, MDAssistant ProfessorUrology
Silvestina DeCoteau, RN, MSN, NEA-BCNursing Program Co-ChairmanAssociate Director of Clinical NursingNursing
Carol FourtuniaSenior Administrative AssistantUrology
Lisa G. Green, MSN, RN, AOCNNurse EducatorNursing
Deborah Hooker, RN, MSN, BC, ACNPNursing Program Co-ChairmanAdvanced Practice NurseUrology
Colleen HubonaDirector, Multidisciplinary Programs and ProjectsProgram Center – Genitourinary
Jay B. Shah, MDAssistant ProfessorUrology
Arlene Siefker-Radtke, MDAssociate ProfessorGenitourinary Medical Oncology
Judi Williams, BSSenior Conference CoordinatorCME/Conference Management
Conference Chairmen
Conference Committee
MDAndersonOrganizingCommittee
Friday,November2,2012Noon RegistrationandGeneralSessionLunch
12:45pm Welcome and Opening Remarks ChristopherG.Wood,MD;andNizarM.Tannir,MD
SESSION I: UROTHELIAL CANCER Session Chairs: Jay B. Shah, MD; and Arlene Siefker-Radtke, MD
Superficial DiseaseModerator: Jay B. Shah, MD
1:00 Basics of Superficial Disease and CIS: The University of Texas MD Anderson Cancer Center Treatment Algorithm
JayB.Shah,MD 1:10 Novel Approaches to Localized Bladder Cancer ColinDinney,MD
1:20 Controversy: T1 High Grade Disease: BCG vs. Cystectomy
BCG is the Best Therapy AshishKamat,MD
Immediate Cystectomy is the Best Therapy ColinDinney,MD
Upper Tract DiseaseModerator: Arlene Siefker-Radtke, MD1:40 Treatment of Superficial Upper Tract Transitional
Cell Carcinoma SurenaMatin,MD
1:50 Role for Neoadjuvant Therapy and LND for Upper Tract Transitional Cell Carcinoma
ArleneSiefker-Radtke,MD
ProgramUrologic Oncology: Advances in Clinical Practice
2:00 Case Presentation: Superficial Bladder Cancer and Upper Tract Tumors
Moderator: Jay B. Shah, MD Panelists: Colin Dinney, MD; Ashish Kamat, MD; Surena Matin, MD;
and Arlene Siefker-Radtke, MD
2:30 Questions and Discussion
2:40 Break
Treatment of Advanced Disease Moderator: Arlene Siefker-Radtke, MD
3:00 Robotic Cystectomy with Intracorporal Urinary Diversion JohnW.Davis,MD 3:10 Bladder Replacement Options O.LenaineWestney,MD 3:20 Controversy: Extent of LND Debate
Extended LND is Necessary H.BartonGrossman,MD
Extended LND is Not Necessary JayB.Shah,MD
3:40 Neoadjuvant Chemotherapy – The University of Texas MD Anderson Cancer Center Treatment Paradigm
FarshidDayyani,MD,PhD 3:50 Controversy: Is There a Role for Radiation in the Curative
Management of Bladder Cancer?
Yes, There is a Role AndrewLee,MD,MPH
No, There is Not a Role RandallMillikan,MD,PhD
4:10 Node Positive Urothelial Cancer: “When to Snip, When to Dip” ArleneSiefker-Radtke,MD
4:20 Questions and Discussion
4:30 Break
4:45 Case Presentations in Bladder Cancer Moderator: Arlene Siefker-Radtke, MD Panelists: John W. Davis, MD; Farshid Dayyani, MD, PhD; Colin Dinney, MD;
H. Barton Grossman, MD; Ashish Kamat, MD; Andrew Lee, MD, MPH; John A. Libertino, MD; Randall Millikan, MD, PhD; Jay B. Shah, MD; and O. Lenaine Westney, MD
5:30 Andrew C. von Eschenbach Lecture JohnA.Libertino,MD
6:15pm AdjournandReception
Saturday,November3,2012
7:00am RegistrationandBreakfast
8:00 Welcome and Opening Remarks ChristopherG.Wood,MD;andNizarM.Tannir,MD
8:05 Distinguished Alumnus Presentation WassimKassouf,MD
SESSION II: KIDNEY CANCER Session Chairs: Christopher G. Wood, MD; and Nizar M. Tannir, MDModerator: Christopher G. Wood, MD
Case Presentation74yearoldWMpresentswithincidentalfindingofa3.5cmincidentalrenalmass.Co-morbiditiesincludeHTNandTypeIIDM.
What is the Best Treatment Option?8:30 The Case for Partial Nephrectomy
JoseA.Karam,MD
8:45 The Case for Thermal Ablation KamranAhrar,MD
9:00 The Case for Active Surveillance SurenaMatin,MD
Case Presentation55yearoldWMpresentswithlocallyadvancedrightrenaltumorwithIVCthrombusuptothehepaticveins.Metastaticevaluationisnegative.
What is the Best Treatment Option?9:15 The Role of Adjuvant and Neoadjuvant Therapy The Role of Lymph Node Dissection in the Treatment of
Kidney Cancer ChristopherG.Wood,MD
9:45 Management of IVC Thrombi in Locally Advanced Renal Cell Carcinoma
JohnA.Libertino,MD
10:00 Questions and Discussion
10:10 Break
Moderator: Nizar M. Tannir, MD
Case Presentation47yearoldWFpresentswithlocallyadvancedleftrenalprimaryandbilateralpulmonarymetastases
What is the Best Treatment Option?Controversy: The Role of Cytoreductive Nephrectomy in the Era of Targeted Therapy
10:25 Upfront Cytoreductive Nephrectomy is the Standard of CareJoseA.Karam,MD
10:40 Pre-surgical Therapy is a Better Standard of Care ChristopherG.Wood,MD
10:55 Immunotherapy for Metastatic Renal Cell Carcinoma: Where We Have Been and Where We are Headed
EricJonasch,MD
11:10 Systemic Targeted Therapy in the Treatment of Metastatic Renal Cell Carcinoma: What is the Right Initial Agent, and What To do at Disease Progression?
NizarM.Tannir,MD
11:25 Stereotactic Radiosurgery for Metastatic Renal Cell Carcinoma: What are the Outcomes?
StephenSettle,MD,PhD
11:40 Questions and Discussion: Renal Case Presentations Moderators: Christopher G. Wood, MD; and Nizar M. Tannir, MD
Panelists: Kamran Ahrar, MD; Eric Jonasch, MD; Jose A. Karam, MD; John A. Libertino, MD; and Surena Matin, MD
12:30pm Lunch
SESSION III: PROSTATE CANCER Session Chairs: Seungtaek Choi, MD; and John W. Davis, MDModerator: John W. Davis, MD
1:15 Topic: Screening / Detection for Prostate Cancer Discussants:JohnW.Davis,MD;RobertB.Evans,PA-C;and
WilliamJ.Graber,MD
1:45 Topic: Low Grade / Volume Prostate Cancer – Treatment Options Discussants:BrianF.Chapin,MD;AndrewLee,MD,MPH;VikasKundra,MD,PhD;ThomasPugh,MD;andJohnF.Ward,MD
2:30 Topic: High Risk / Locally Advanced Prostate Cancer – Treatment Options
Discussants:BrianF.Chapin,MD;PaulCorn,MD;andSeanMcGuire,MD,PhD
3:15 Break
3:30 Topic: Lymph Node Positive Prostate Cancer Discussants:BrianF.Chapin,MD;KarenHoffman,MD;and
LancePagliaro,MD
4:00 Topic: Recurrent / Metastatic Disease Discussants:AnaAparicio,MD;BrianF.Chapin,MD;and
SeungtaekChoi,MD
4:45 Case Presentations in Prostate Cancer Moderator: Seungtaek Choi, MD Panelists: Ana Aparicio, MD; Brian F. Chapin, MD; Paul Corn, MD;
John W. Davis, MD; Karen Hoffman, MD; Lance Pagliaro, MD; and John F. Ward, MD
5:30pm Closing Remarks and Adjourn ChristopherG.Wood,MD
Kamran Ahrar, MDDiagnostic Radiology Ana Aparicio, MDGenitourinary Medical Oncology
Brian F. Chapin, MDUrology
Seungtaek Choi, MDRadiation Oncology
Paul Corn, MDGenitourinary Medical Oncology
John W. Davis, MDUrology
Farshid Dayyani, MD, PhDGenitourinary Medical Oncology
Colin Dinney, MDUrology
Robert B. Evans, PA-CUrology
William J. Graber, MDUrology
MD Anderson FacultyH. Barton Grossman, MDUrology
Karen Hoffman, MDRadiation Oncology
Eric Jonasch, MDGenitourinary Medical Oncology
Ashish Kamat, MDUrology
Jose A. Karam, MDUrology
Vikas Kundra, MD, PhDDiagnostic Radiology
Andrew Lee, MD, MPHRadiation Oncology
Surena Matin, MDUrology
Sean McGuire, MD, PhDRadiation Oncology
Randall Millikan, MD, PhDGenitourinary Medical Oncology
Lance Pagliaro, MDGenitourinary Medical Oncology
Thomas Pugh, MDRadiation Oncology
Stephen Settle, MD, PhD Radiation Oncology
Jay B. Shah, MDUrology
Arlene Siefker-Radtke, MDGenitourinary Medical Oncology
Nizar M. Tannir, MD Genitourinary Medical Oncology
John F. Ward, MDUrology
O. Lenaine Westney, MDUrology
Christopher G. Wood, MDUrology
Andrew C. von Eschenbach LectureJohn A. Libertino, MDChair, Institute of Urology Lahey Clinic Medical CenterProfessor of UrologyTufts UniversityBurlington, Massachusetts
Guest Faculty
Distinguished AlumniWassim Kassouf, MDProgram DirectorMcGill Urology ResidencyAssistant ProfessorDepartment of Surgery McGill University Health CenterMontreal, Canada
Reena W. Cherry, MS, PA-CPhysician AssistantGenitourinary Medical Oncology
Silvestina DeCoteau, RN, MSN, NEA-BCAssociate Director of Clinical NursingNursing
Deborah Hooker, RN, MSN, BC, ACNPAdvanced Practice NurseUrology
Irene A. Inguillo, BSN, RN, CURNClinical Nurse, OutpatientGU Center, Medical Oncology
Lydia T. Madsen, RN, MSN, CNSAdvanced Practice NurseGenitourinary Medical Oncology
Robert L. Massey, PhD, RN, NEA-BCAssistant ProfessorNursing
William E. Osai, RN, MSN, FNP-CAdvanced Practice NurseGenitourinary Medical Oncology
Cynthia A. Worley, BSN, RN, CWOCNWound Ostomy Continence NurseNursing
Urologic Oncology:
Nursing Advances in Clinical Practice
Educational ObjectivesAfterattendingthiseducationalactivity,participantsshouldbeableto• Describethegenitourinaryanatomyindetail;• IdentifypatientswhoarecandidatesforPSAscreeningaccordingtocurrentguidelinesandthenewPSAcontroversy;
• DiscussthetreatmentoptionsandmodalitiesofferedtonewlydiagnosedprostatecancerpatientsthroughtheMultidisciplinaryClinic;
• Identifyurothelialcancerpatientswhoaresurgicalcandidates,discusstheirpost-operativecaremanagement,anddescribeacutepost-operativecomplicationsandinterventionrationales;
• Explainthepsychologicalimpactofurinarydiversions/ostomiesanddiscussmanagement;• Discusstreatmentmodalitiesforrenaltumorobservationversussurgeryandexplaintherationaleforboth;
• DescribetherationaleandguidelinesfortheGUCancerSurvivorshipProgramandidentifythepatientbenefits.
Accreditation/Credit DesignationNursingContinuingEducationContactHourswillbeprovided.
TheUniversityofTexasMDAndersonCancerCenterisanapprovedproviderofcontinuingnursingeducationbytheTexasNursesAssociation,anaccreditedapproverbytheAmericanNursesCredentialingCenter’sCommissiononAccreditation.
MDAndersonNursingSessionFaculty
NursingSessionProgram
7:30am RegistrationandContinentalBreakfast PosterSession
8:00 Welcome and Opening Remarks DeborahHooker,RN,MSN,BC,ACNP NursingProgramCo-Chairman
8:05 Anatomical Review – Genitourinary System IreneA.Inguillo,BSN,RN,CURN8:15 Prostate Cancer Screening: Current Guidelines and
PSA Controversies DeborahHooker,RN,MSN,BC,ACNP
9:00 Multidisciplinary Prostate Cancer Clinic: What are the treatment options?
LydiaT.Madsen,RN,MSN,CNS
9:45 BreakandPosterSession
10:00 Urothelial Cancer: Candidates for Surgical Intervention Post-Operative Care and Acute Post-Operative Complications
SilvestinaDeCoteau,RN,MSN,NEA-BC;andRobertL.Massey,PhD,RN,NEA-BC
10:40 Psychological Impact and Management of Urinary
Diversion / Ostomy CynthiaA.Worley,BSN,RN,CWOCN 11:00 Renal Tumor Treatment Modalities: Surgery vs. Observation ReenaW.Cherry,MS,PA-C
11:45 Survivorship Clinic: Rationale and Benefits WilliamE.Osai,RN,MSN,FNP-C
12:15pm Closing Remarks and Evaluations SilvestinaDeCoteau,RN,MSN,NEA-BC NursingProgramCo-Chairman
Friday,November2,2012
Urologic Oncology: Nursing Advances in Clinical PracticeOn-siteregistrationopensat7:30amonFriday, November 2, 2012.Theconferencewillbeginat8:00amandendat12:15pmonFriday,November2,2012.
ThosewishingtoattendthegeneralconferencethatbeginsonFriday,November2,2012at12:45pmandendsonSaturday,November3,2012at5:30pmmustpayanadditionalfeeof$50.00.Pleaseseetheregistrationformforinstructions.
Urologic Oncology: Advances in Clinical PracticeOn-siteregistrationopensatNoononFriday, November 2, 2012.Theconferencewillbeginat12:45pmonFriday, November 2, 2012andadjournonSaturday,November3,2012at5:30pm.Advanceregistrationisencouragedasspaceandmaterialsarelimited.Pleaseseetheregistrationformforapplicablefees.
Thefullconferenceregistrationfeeincludesthetuition,syllabus,breakfasts,breaks,lunches,andreception.
The deadline for advance registration is Friday, October 19, 2012.
There are three ways to register:•Mailto:CME/ConferenceManagement–Unit1381,TheUniversityofTexasMDAndersonCancerCenter,P.O.Box301439,Houston,TX77230-1439
•Faxto:713-794-1724•On-lineatwww.mdanderson.org/conferences
We accept the following forms of payment:•Check(payablethroughU.S.banksonly)•MoneyOrder•CreditCards(MasterCard,VISA,andAmericanExpress)•Cash(on-siteregistrationonly)
Whenregisteringonlineareceipt/confirmationletterwillbeautomaticallye-mailedtothee-mailaddressyoulistontheregistrationform.Ifyouregisterbyfaxormail,areceipt/confirmationletterwillbesenttoyouwithintenworkingdaysofreceiptofyourfee.
Registration Information
Refund/CancellationPolicy Theregistrationfee,minusa$50administrativehandlingfee,isrefundableifawrittenrequestisreceivedonorbeforeOctober 19, 2012.Norefundswillbegrantedafterthatdate.Therequestforaregistrationrefundmustincludethetaxidentificationnumberofthecompanyorinstitutionifregistrationwaspaidbyacompanyorinstitutioncheck.
TheDepartmentofCME/ConferenceManagementreservestherighttocancelactivitiespriortothescheduleddate,iflowenrollmentorothercircumstancesmakeitnecessary.Eachregistrantwillbenotifiedbymail,e-mail,oratthephoneorfaxnumbersgivenontheregistrationform.Incaseofactivitycancellation,theliabilityoftheDepartmentofCME/ConferenceManagementislimitedtotheregistrationfee.CME/ConferenceManagementwillrefundthefullregistrationfee.
TheDepartmentofCME/ConferenceManagementreservestherighttolimitthenumberofparticipantsinaprogramandisnotresponsibleforanyexpensesincurredbyanindividualwhoseregistrationisnotconfirmedandforwhomspaceisnotavailable.
SpecialAssistanceContacttheDepartmentofCME/ConferenceManagementat713-792-2223ortollfreeat866-849-5866ifyouhaveanyspecialdietaryorADAaccommodationneeds.
Accommodations• AblockofroomshasbeenreservedforconferenceattendeesattheHouston Marriott at the Texas Medical Center,6580FanninStreet,Houston,Texas.• Earlyhotelreservationissuggested.Tomakereservations,pleasecallMarriott Reservationsat800-228-9290andidentifyyourselfaspartoftheUrologic
Oncology MD Anderson Room BlockgroupstayingattheHoustonMarriottattheTexasMedicalCenter.
• Thespecialmeetingrateis$112.00singleordoubleoccupancy.Pleaseadd17% TexasStateandlocaltaxes.ReservationsanddepositsreceivedafterOctober 18, 2012willbeconfirmedifspaceisavailableandatcurrenthotelpublishedguestroomrates.
Please let us know what specific topics, issues or questions you wish to see addressed or emphasized in this activity. Fax or e-mail CME/Conference Management. All responses will be forwarded to the Program Chairs for consideration.
GroundTransportation (prices are subject to change and variable depending on location of conference)• Houstonisservedbytwoairports,GeorgeBushIntercontinental(IAH)andWilliamP.Hobby(HOU).
• Taxicabsareavailableatanestimatedcostof$50-60,toorfromWilliamP.HobbyAirportorGeorgeBushIntercontinentalAirport.
• SuperShuttleoperatesashuttlebusbetweenGeorgeBushIntercontinentalAirportandtheHoustonMarriottattheTexasMedicalCenterfor$27one-wayand$54round-trip.Formoreinformation,call713-523-8888ortoll-freeat800-258-3826oron-lineatwww.supershuttle.com.
• SuperShuttleoperatesashuttlebusbetweenWilliamP.HobbyAirportandtheHoustonMarriottattheTexasMedicalCenterfor$24one-wayand$48round-trip.Formoreinformation,call713-523-8888ortoll-freeat800-258-3826oron-lineatwww.supershuttle.com.
The University of Texas MD Anderson Cancer Center has implemented a process whereby everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest that could potentially affect the information presented. MD Anderson also requires that all faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products. Specific disclosure will be made to the participants prior to the educational activity.
Agendas are subject to change because we are always striving to improve the quality of your educational experience. MD Anderson may substitute faculty with comparable expertise on rare occasions necessitated by illness, schedule conflicts, and so forth.
Photographing, audio taping and videotaping are prohibited.
CON
FERE
NCE
REG
ISTR
ATIO
N -
0592
7th
Urol
ogic
Onco
logy
: Adv
ance
s in
Clin
ical
Pra
ctice
— N
ovem
ber 2
-3, 2
012
Nursi
ng Se
ssion
Urol
ogic
Onco
logy
: Nur
sing A
dvan
ces i
n Cl
inic
al P
ract
ice —
Nov
embe
r 2, 2
012
Last
Nam
e
Fi
rst
M
I
H
ighe
st D
egre
e
Depa
rtmen
t (in
clud
e bo
x no
.)
Spe
cial
ty
Inst
itutio
n
Phy
sici
an:
o
Yes
oN
oSt
reet
C
ity
S
tate
/For
eign
Cou
ntry
/Zip
or M
ail C
ode
Dayt
ime
Phon
e (w
ith a
rea
code
)
Ce
ll Ph
one
(with
are
a co
de)
Fax
(with
are
a co
de)
E-m
ail A
ddre
ss
E
mer
genc
y Co
ntac
t
P
hone
(with
are
a co
de)
Char
ge th
e fo
llow
ing:
o
VISA
oM
aste
rCar
d
o
Amer
ican
Exp
ress
Cred
it Ca
rd N
umbe
r or M
D An
ders
on In
terd
epar
tmen
tal T
rans
fer (
IDT)
No.
Expi
ratio
n Da
te
Cred
it Ca
rd H
olde
r Nam
e (F
irst/L
ast)
C
redi
t Car
d Ho
lder
Bill
ing
Addr
ess
& Z
IP C
ode
Auth
orize
d Si
gnat
ure
REQU
IRED
for c
redi
t car
d or
IDT
MD
Ande
rson
Em
ploy
ee ID
No.
(REQ
UIRE
D)
IDT
Appr
over
Nam
e (F
irst/L
ast)
plea
se p
rint
IDT
Appr
over
E-m
ail
THIS
IS N
OT A
SEL
F-M
AILE
R - A
ddre
ss to
: 7t
h Ur
olog
ic O
ncol
ogy:
Adv
ance
s in
Clin
ical
Pra
ctic
e
Nur
sing
Ses
sion
Urol
ogic
Onc
olog
y: N
ursi
ng A
dvan
ces
in
Clin
ical
Pra
ctic
eDe
partm
ent o
f CM
E/Co
nfer
ence
Man
agem
ent
Unit
1381
The
Univ
ersi
ty o
f Tex
as M
D An
ders
on C
ance
r Cen
ter
PO B
ox 3
0143
9, H
oust
on, T
X 77
230-
1439
or fa
x to
713
-794
-172
4 M
ake
chec
k or
mon
ey o
rder
pay
able
to:
The
Univ
ersi
ty o
f Tex
as M
D An
ders
on C
ance
r Cen
ter
GENE
RAL C
ONFE
RENC
E RE
GIST
RATI
ON FE
ESPh
ysic
ians
1 P
ostm
arke
d be
fore
Oct
. 19,
2012
.......
........
.$25
0.00
1 P
ostm
arke
d af
ter O
ct. 1
9, 20
12 ...
........
........
$300
.00
Stud
ents
/Tra
inee
s/PA
s1 P
ostm
arke
d be
fore
Oct
. 19,
2012
.......
........
.$55
.00
1 P
ostm
arke
d af
ter O
ct. 1
9, 20
12 ...
........
........
$80.0
0
NURS
E SE
SSIO
N RE
GIST
RATI
ON FE
ES 1
Pos
tmar
ked
befo
re O
ct. 1
9, 20
12 ...
........
.....$
45.00
1
Pos
tmar
ked
afte
r Oct
. 19,
2012
.......
........
....$5
5.00
Gene
ral C
onfe
renc
e Fe
e - N
urse
s 1
.......
........
........
........
........
........
........
........
........
.....$
50.00
Depa
rtmen
t of C
ME/
Conf
eren
ce M
anag
emen
t - U
nit 1
381
The
Univ
ersi
ty o
f Tex
as M
D An
ders
on C
ance
r Cen
ter
#176
700/
3007
0592
PO B
ox 3
0143
9Ho
usto
n, T
X 77
230-
1439
Non
-Pro
fit O
rg.
U.S.
Pos
tage
PAID
Perm
it N
o. 7
052
Hous
ton,
TX